- Home
- GGR vs PDSB Comparison
GGR vs PDSB Comparison
Compare GGR & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGR
- PDSB
- Stock Information
- Founded
- GGR 2011
- PDSB 2005
- Country
- GGR Taiwan
- PDSB United States
- Employees
- GGR N/A
- PDSB N/A
- Industry
- GGR Auto Manufacturing
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- GGR Consumer Discretionary
- PDSB Health Care
- Exchange
- GGR Nasdaq
- PDSB Nasdaq
- Market Cap
- GGR 80.6M
- PDSB 72.2M
- IPO Year
- GGR N/A
- PDSB N/A
- Fundamental
- Price
- GGR $0.32
- PDSB $1.17
- Analyst Decision
- GGR Hold
- PDSB Strong Buy
- Analyst Count
- GGR 2
- PDSB 2
- Target Price
- GGR $0.50
- PDSB $10.00
- AVG Volume (30 Days)
- GGR 548.2K
- PDSB 467.6K
- Earning Date
- GGR 08-14-2025
- PDSB 08-12-2025
- Dividend Yield
- GGR N/A
- PDSB N/A
- EPS Growth
- GGR N/A
- PDSB N/A
- EPS
- GGR N/A
- PDSB N/A
- Revenue
- GGR $304,551,000.00
- PDSB N/A
- Revenue This Year
- GGR N/A
- PDSB N/A
- Revenue Next Year
- GGR $5.00
- PDSB N/A
- P/E Ratio
- GGR N/A
- PDSB N/A
- Revenue Growth
- GGR N/A
- PDSB N/A
- 52 Week Low
- GGR $0.19
- PDSB $0.85
- 52 Week High
- GGR $1.65
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- GGR 53.87
- PDSB 35.94
- Support Level
- GGR $0.36
- PDSB $1.20
- Resistance Level
- GGR $0.40
- PDSB $1.40
- Average True Range (ATR)
- GGR 0.03
- PDSB 0.10
- MACD
- GGR 0.01
- PDSB -0.02
- Stochastic Oscillator
- GGR 46.82
- PDSB 4.26
About GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.